Monthly Archives: November 2007

At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so I said that VCs generally expect that 1/3 of their investments will see great returns, 1/3 will see modest or no returns, and 1/3 will not be profitable.

VC Fred Wilson as Union Square Ventures recently analyzed his career in venture capital and posted his results. He’s got an enviable record of only 20% of deals failing to deliver, and more than 1/3 delivering a greater than 5x return.

Fred’s not into biotech, so I’d be hesitant about applying these numbers to biotechnology investing, and I’d be interested to see what the trends are in biotech VC.

Bio-Rad’s got an interesting website up: RethinkPCR.

The company’s name isn’t posted on the front page, but is readily available in the contest terms and conditions and privacy policy. It’s an interesting strategy to acquire consumer intelligence. Of course, consumers don’t always ask for what they want — they tend to ask for incremental improvements rather than revolutions, and they may not even accept the changes they ask for — but it will be interesting to see if any innovative new PCR products emerge.

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in November 2007
*Drugs may be covered by more than one patent

Tradename Applicant Generic Name Patent Number Patent Expiration
ANDRODERM Watson Labs testosterone 4,849,224 NOV 12,2007
ANDRODERM Watson Labs testosterone 4,983,395 NOV 12,2007
AVITA Mylan Bertek tretinoin 4,971,800 NOV 20,2007
COMTAN Orion entacapone 4,963,590 NOV 27,2007
ELOCON Schering mometasone furoate 4,775,529 NOV 21,2007
FLECTOR Inst Biochem diclofenac epolamine 4,948,805 NOV 09,2007
MERIDIA Abbott sibutramine hydrochloride 4,929,629 NOV 29,2007
MYLOTARG Wyeth Pharms Inc gemtuzumab ozogamicin 4,970,198 NOV 30,2007
PROVIGIL Cephalon modafinil 4,927,855 NOV 22,2007
STALEVO 100 Orion carbidopa; entacapone; levodopa 4,963,590 NOV 27,2007
STALEVO 150 Orion carbidopa; entacapone; levodopa 4,963,590 NOV 27,2007
STALEVO 50 Orion carbidopa; entacapone; levodopa 4,963,590 NOV 27,2007
TOPROL-XL Astrazeneca metoprolol succinate 4,927,640 NOV 22,2007
TYLENOL (CAPLET) Mcneil Cons acetaminophen 4,968,509 NOV 06,2007
URSO 250 Axcan Scandipharm ursodiol 4,859,660 NOV 19,2007
URSO FORTE Axcan Scandipharm ursodiol 4,859,660 NOV 19,2007

Courtesy of DrugPatentWatch.com